LOULLA&PHILLA

Development of 6-mercaptopurine and Methotrexate oral liquid formulations for the maintenance treatment of Acute Lymphoblastic Leukæmia in children

 Coordinatore Only For Children Pharmaceuticals 

 Organization address address: Rue Henri Barbusse 35 bis
city: Paris
postcode: 75005

contact info
Titolo: Dr.
Nome: Vincent
Cognome: Grek
Email: send email
Telefono: +33 6 62889643

 Nazionalità Coordinatore France [FR]
 Totale costo 4˙244˙817 €
 EC contributo 3˙316˙415 €
 Programma FP7-HEALTH
Specific Programme "Cooperation": Health
 Code Call FP7-HEALTH-2007-B
 Funding Scheme CP-FP
 Anno di inizio 2008
 Periodo (anno-mese-giorno) 2008-11-01   -   2012-04-30

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    Only For Children Pharmaceuticals

 Organization address address: Rue Henri Barbusse 35 bis
city: Paris
postcode: 75005

contact info
Titolo: Dr.
Nome: Vincent
Cognome: Grek
Email: send email
Telefono: +33 6 62889643

FR (Paris) coordinator 1˙440˙678.80
2    VENN LIFE SCIENCES (FRANCE)

 Organization address city: Paris

contact info
Titolo: Mr.
Nome: Grégoire
Cognome: Lacroix
Email: send email
Telefono: +33 1 40 21 19 72
Fax: +33 1 40 21 94 95

FR (Paris) participant 535˙530.00
3 Laboratoire Philippe Davioud FR participant 308˙499.60
4    REGION HOVEDSTADEN

 Organization address address: KONGENS VAENGE 2
city: HILLEROD
postcode: 3400

contact info
Titolo: Prof.
Nome: Kjeld
Cognome: Schmiegelow
Email: send email
Telefono: +45 3 5451357
Fax: +45 3 5454524

DK (HILLEROD) participant 259˙941.60
5    FRANCE EUROPE INNOVATION

 Organization address address: RUE DES RENAUDES 32
city: PARIS
postcode: 75017

contact info
Titolo: Mr.
Nome: Olivier
Cognome: Degrand
Email: send email
Telefono: +33 1 47 43 11 28

FR (PARIS) participant 186˙091.20
6    ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS

 Organization address address: 3 Avenue Victoria
city: PARIS
postcode: 75004

contact info
Titolo: Prof.
Nome: Christophe
Cognome: Misse
Email: send email
Telefono: +33 1 44 84 17 70
Fax: +33 1 44 84 17 88

FR (PARIS) participant 185˙214.00
7    HEINRICH-HEINE-UNIVERSITAET DUESSELDORF

 Organization address address: UNIVERSITAETSSTRASSE 1
city: DUSSELDORF
postcode: 40225

contact info
Titolo: Mr.
Nome: Uwe
Cognome: Droste
Email: send email
Telefono: +49 2118112245
Fax: +49 211811409

DE (DUSSELDORF) participant 110˙400.00
8    CHRISTIAN-ALBRECHTS-UNIVERSITAET ZU KIEL

 Organization address address: OLSHAUSENSTRASSE 40
city: KIEL
postcode: 24118

contact info
Titolo: Ms.
Nome: Susanne
Cognome: Neufeldt
Email: send email
Telefono: +49 431 8807246
Fax: +49 431 8801560

DE (KIEL) participant 72˙000.00
9    PharmaFlow Ltd

 Organization address address: Lisbunny Industrial Estate
city: Co Tipperary

contact info
Titolo: Mr.
Nome: Finbarr
Cognome: Cremin
Email: send email
Telefono: +353 67 41575
Fax: + 353 67 42009

IE (Co Tipperary) participant 69˙873.50
10    HOSPICES CIVILS DE LYON

 Organization address address: 3 Quai des Celestins
city: LYON
postcode: 69229

contact info
Titolo: Ms.
Nome: Cecile
Cognome: Legros
Email: send email
Telefono: +33 4 72 11 54 22
Fax: +33 4 72 11 51 90

FR (LYON) participant 54˙000.00
11    CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE

 Organization address address: AVENUE OSCAR LAMBRET 2
city: LILLE
postcode: 59037

contact info
Titolo: Ms.
Nome: Florence
Cognome: Nosal
Email: send email
Telefono: +33 3 204 457 51
Fax: +33 3 204 466 30

FR (LILLE) participant 47˙895.40
12    CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES

 Organization address address: Allee de l'Ile Gloriette 5
city: NANTES
postcode: 44093

contact info
Titolo: Ms.
Nome: Anne
Cognome: Brethet
Email: send email
Telefono: +33 2 53 48 28 25
Fax: +33 2 53 48 28 26

FR (NANTES) participant 46˙291.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

clinicians    aelig    emea    liquid    clinical    children    oral    drug    methotrexate       pediatric    mercaptopurine   

 Obiettivo del progetto (Objective)

'Only for Children Pharmaceuticals, a French based Small and Medium-sized Enterprise (SME) developing drug for children, is the Coordinator of a multinational, multidisciplinary and complementary Consortium. This Consortium is composed of highly qualified organizations and notorious clinicians in pediatric hemato-oncology. The Consortium is an integrated team of competencies (clinicians, pædiatricians, pharmacokineticists, pharmacists, manufacturers, engineers, regulatory and ethical experts) capable of executing a pædiatric drug development from its designing to market. The Consortium will perform the non-clinical development of Methotrexate (MTX) and the non-clinical and clinical development of 6-Mercaptopurine (6MP) oral liquid formulations adapted for maintenance treatment of pediatric acute lymphoblastic leukemia with the crucial objective to make available these adapted formulation by 2012 at the latest. Methotrexate and 6-mercaptopurine are on the EMEA Priority list of off-patent medicinal products of paediatric working party of the European medicine agency - June 2007. On September 2007, EMEA’s COMP Committee has granted the orphan status to Methotrexate (oral liquid) and 6-mercaptopurine (oral liquid).'

Altri progetti dello stesso programma (FP7-HEALTH)

EDUFLUVAC (2013)

Combinatorial immunization strategy to educate the immune system towards cross recognition and coverage against antigenic drift in seasonal influenza virus exposure

Read More  

OPTISTEM (2009)

Optimization of stem cell therapy for clinical trials of degenerative skin and muscle diseases

Read More  

CHILD-EU (2012)

Orphans Unite: chILD better together – European Management Platform for Childhood Interstitial Lung Diseases

Read More